Salute e Benessere

Global Diabetic Foot Ulcer (DFU) Treatment Market Set to Surpass $7.2 Billion by…

Download PDF Brochure: https://www.marketresearchintellect.com/download-sample/?rid=222176 Download PDF Brochure: https://www.marketresearchintellect.com/download-sample/?rid=222176 202 - Pages 126 – Tables 37 – Figures Scope Of The Report Diabetic Foot Ulcer (DFU) Treatment Market Overview Geographic Dominance : North Americaholds the dominant position in the global Diabetic Foot Ulcer (DFU) treatment market, accounting for the largest share of revenue...
PR Newswire
22/10/2024

Harnessing Generative AI in Healthcare and Improving Cardiometabolic Health with…

GenAI, powered by advancements like ChatGPT-4, is reshaping healthcare by optimizing workflows, reducing costs, and improving patient care. However, to fully harness its capabilities, healthcare organizations must begin implementing GenAI in foundational areas such as documentation and knowledge management, before scaling across the healthcare value chain. Additionally, organizations need to address cybersecurity concerns, as healthcare faces a growing threat of cyberattacks, with projected…
PR Newswire
22/10/2024

Cosmetic Pigments Market Set to Reach USD 4.5 Billion by 2031, Driven by…

Download PDF Brochure: https://www.marketresearchintellect.com/download-sample/?rid=245181 Download PDF Brochure: https://www.marketresearchintellect.com/download-sample/?rid=245181 202 - Pages 126 – Tables 37 – Figures Scope Of The Report Cosmetic Pigments Market Overview Market Definition and Scope The cosmetic pigments market includes a variety of colorants used in personal care and beauty products to enhance appearance. These pigments are crucial for...
PR Newswire
22/10/2024

Orthopedic Braces and Supports Market is expected to generate a revenue of USD…

As the demand for orthopedic braces and supports continues to rise due to increasing cases of musculoskeletal disorders, injuries, and an aging population, businesses need a clear understanding of the competitive landscape, innovations, and regulatory environment that influence market growth. This report delves into each of these factors and offers detailed forecasts to guide your organization's investment decisions and market strategies. As the demand for orthopedic braces and supports...
PR Newswire
22/10/2024

Oral Proteins and Peptides Market to Hit USD 20.36 Billion by 2029 with 22.5%…

Browse in-depth TOC on "Oral Proteins and Peptides Market" Browse in-depth TOC on "Oral Proteins and Peptides Market" 407 - Tables53 - Figures318 - Pages Based on molecule, the oral proteins and peptides market is segmented into trofinetide, semaglutide, linaclotide, voclosporin, plecanatide, calcitonin and others. The semaglutide segment accounted for the largest share of the oral proteins and peptides market. This can be owing to increasing prevalence of diabetes and...
PR Newswire
22/10/2024

NEJM Group: First to Market with Tangent90's Solution for Increasing Exposure to…

The launch of NEJM Group Resource Center signifies a shift in how pharmaceutical companies can engage with medical publishers' vast repositories of content, including original articles, article summaries, related videos, review articles, correspondence, images, etc. By leveraging Tangent90's cutting-edge technology, NEJM Group aims to streamline content access for pharmaceutical partners, enhancing collaboration and efficiency within the industry. The launch of NEJM Group Resource Center...
PR Newswire
22/10/2024

KFSHRC Stands as the World's Largest Kidney Paired Transplant program, with 500…

Solidifying its Leading Role in Providing Innovative Solutions for Kidney Failure Patients RIYADH, Saudi Arabia, Oct.22, 2024(GLOBE NEWSWIRE) -- In a step that solidifies its position as a leading healthcare institution regionally and internationally, King Faisal Specialist Hospital and Research Centre (KFSHRC) celebrated its success in performing 500 paired kidney transplants since the inception of its Kidney Paired Donation Program in 2011. This unprecedented achievement, unmatched...
Nasdaq GlobeNewswire
22/10/2024

Breaking Barriers in Healthcare Simulation: AVL and InSilicoTrials

InSilicoTrials effectively leverages XPS (eXtended Particle Simulations), a sophisticated DEM (Discrete Element Method) simulation software, to provide detailed predictions of fluid-granular processes in pharmaceutical manufacturing. XPS – developed by the Research Center Pharmaceutical Engineering (RCPE) enables precise control and prediction of unit operations with its advanced contact models and massively parallel algorithms optimized for GPUs. This capability ensures unmatched accuracy and…
PR Newswire
22/10/2024

Enhanced Data Security and Quality via ISO 27001:2022 and SOC 2 Certifications…

As Moon Surgical harnesses Maestro's powerful computing and sensing abilities to drive Maestro's ScoPilot™ and other advanced digital capabilities, ISO 27001 and SOC 2 compliance will help ensure the Maestro ecosystem is built on a security, quality, and compliance foundation. The certifications are vital in transforming raw data into valuable and actionable insights that healthcare providers can confidently use in the OR and beyond. As Moon Surgical harnesses Maestro's powerful computing and...
PR Newswire
22/10/2024

Recursion announces first patient dosed in Phase 2 clinical study of REC-3964, a…

REC-3964 is Recursion's first new chemical entity developed using the RecursionOS.REC-3964 represents a novel, non-antibiotic approach with a unique mechanism of action that binds and blocks catalytic activity of the toxin's innate glucosyltransferase in order to inhibit the toxin produced byC. diff.in the gastrointestinal tract.There are up to 175,000 cases of recurrentC. diff.each year and more than 29,000 patients die in the U.S. fromC. diff.annually. Rates of recurrentC...
Nasdaq GlobeNewswire
22/10/2024

First participants enrolled in first-in-human Phase I clinical trial with…

Pre-clinical data show that NOP receptor agonists have the potential to act as potent analgesics without abuse liability.1 Leveraging the clinical data Grünenthal obtained during the development of its NOP receptor programme, Grünenthal now brings forward a candidate that shows best-in-class potency and selectivity for the NOP receptor. These properties are predicted to provide robust pain relief in a broad range of chronic pain indications without the serious central nervous system related side…
PR Newswire
22/10/2024

Biogen Announces Late Breaker and New Data Presentations at American Society of…

Late breaker oral presentation to feature final results of the Phase 2 IGNAZ study of felzartamab for IgA nephropathyAdditional oral presentation to examine the impact of felzartamab on key disease-relevant biomarkersFelzartamab, an investigational anti-CD38 monoclonal antibody, is a potential first-in-class therapeutic candidate for a range of rare immune-mediated indications with planning underway for Phase 3 developmentCAMBRIDGE, Mass., Oct.22, 2024(GLOBE NEWSWIRE) --Biogen...
Nasdaq GlobeNewswire
22/10/2024

Cheshire and Merseyside Health and Care Partnership Secure Patient Care with…

"Cynerio delivered exactly what we needed: comprehensive visibility into all networked medical devices across our ICS trusts. Deployment was efficient, and the vendor's support was consistently responsive, helping us enhance our security posture and fortify our cybersecurity defences." said Matt Connor, Chief Digital Information Officer at Liverpool Womens Hospital NHS Foundation Trust. "Cynerio delivered exactly what we needed: comprehensive visibility into all networked medical…
PR Newswire
22/10/2024

Gradient Denervation Technologies Appoints Stanton Rowe to Board of Directors…

Serial entrepreneur and medical device industry executive adds key experience to board of directors Rowe has developed multiple innovative medical technologies through his current incubator, Nidus Biomedical, and with his prior incubator, NXT Biomedical. He served as Chief Scientific Officer of Edwards Lifesciences and was co-founder and CEO of Percutaneous Valve Technologies, the developer of the first transcatheter aortic valve replacement device which was later acquired by Edwards...
Nasdaq GlobeNewswire
22/10/2024

Telix Spins Off Rhine Pharma™ to Expand Global Access to Radiopharmaceuticals

Because 99mTc and 188Re can each be produced using on-site generators, they enable a highly-differentiated solution for regions with limited radiopharmaceutical manufacturing infrastructure or dispersed populations. 99mTc enables imaging of patients with widely available SPECT scanners, while 188Re has demonstrated potential as a therapeutic isotope, thanks to its high-energy beta emission that maximises damage to tumour cells. Its short half-life (16.9 hours) also has the potential to simplify…
PR Newswire
22/10/2024

Alvotech and Teva Announce U.S. FDA Approval of Additional Presentation of…

Approval of SELARSDI 130 mg/26 mL in a single-dose vial for intravenous infusion expands label to include treatment of adults with Crohn's disease and ulcerative colitisThe FDA previously approved SELARSDI 45 mg/0.5 mL and 90 mg/mL in a single-dose prefilled syringe for subcutaneous injection in April 2024SELARSDI's U.S. launch for all indications is expected in Q1 2025 REYKJAVIK, Iceland & PARSIPPANY, N.J., Oct.22, 2024(GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO) and...
Nasdaq GlobeNewswire
22/10/2024

Alvotech and Teva Announce U.S. FDA Approval of Additional Presentation of…

Approval of SELARSDI 130 mg/26 mL in a single-dose vial for intravenous infusion expands label to include treatment of adults with Crohn's disease and ulcerative colitisThe FDA previously approved SELARSDI 45 mg/0.5 mL and 90 mg/mL in a single-dose prefilled syringe for subcutaneous injection in April 2024SELARSDI's U.S. launch for all indications is expected in Q1 2025Alvotech (NASDAQ: ALVO) and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd...
Nasdaq GlobeNewswire
22/10/2024

KFSHRC Leads the Kingdom's Position on the Global Medical Tourism Map

Providing Care to International Patients from 17 Countries Worldwide RIYADH, Saudi Arabia, Oct.22, 2024(GLOBE NEWSWIRE) -- With the growing global interest in medical tourism, the Kingdom's healthcare sector strives to solidify its position as a distinguished hub for advanced medical treatments, transitioning from being a provider of outbound medical tourism to attracting 5% of the global patients who seek treatment abroad. Leading this initiative is King Faisal Specialist Hospital...
Nasdaq GlobeNewswire
22/10/2024

Oblique Therapeutics announces that NaV 1.8 project is advancing to next stage

"In the scientific community there is a general agreement that TRPV1 and NaV 1.8 are the two most promising targets for new treatments against chronic pain. I'm therefore pleased that we have reached this important milestone in our NaV 1.8 project that was only started in the late spring this year. I'm convinced that our advanced TRPV1 program with two highly promising classes of molecules together with the NaV 1.8 project will position Oblique Therapeutics among the leaders in the pain…
PR Newswire
22/10/2024

Rowenta, a brand of Groupe SEB, and Narwal Unveil Co-Engineered X-CLEAN 10 in…

As the world reference in small domestic equipment, Groupe SEB has a unique portfolio of top brands including Rowenta, Tefal, WMF and Krups… Rowenta, which celebrates 140 years of excellence this year, is one of its flagship brands and continues to drive innovation in household appliances. Rowenta's success has been bolstered by its presence within Groupe SEB's diverse ecosystem, allowing it to thrive in key categories such as Personal Care, Home Comfort, Linen Care and Floor Care, depending on…
PR Newswire
22/10/2024

World Psoriasis Day 2024: Psoriatic Disease and Family--Standing Together in…

The report highlights how psoriatic disease disrupts routines, increases household responsibilities, and alters leisure activities. Families find themselves navigating practical and emotional challenges together, often without adequate support. This report emphasizes the vital but often unrecognized role that family members play in managing the disease—offering care during flare-ups and emotional reassurance while grappling with their own feelings of helplessness and frustration. The report...
PR Newswire
22/10/2024

EBC 24 – Conference Programme Unveiled

Europe's leading business and discussion forum within the global bioplastics sector, the European Bioplastics Conference (EBC 24), has just released its programme. The conference will be held on 10-11 December 2024, in Berlin and online, bringing together industry leaders, innovators, and experts to share insights on the latest advancements in bioplastics.The first session will focus on key policy factors shaping the bioplastics industry and will be opened with a keynote by Kristin...
Nasdaq GlobeNewswire
22/10/2024

Ariceum Therapeutics Presents Outstanding Data on its First-in-Class…

Results demonstrate that 225Ac-satoreotide shows the strongest anti-tumoural effect in vivo at a low single dose when evaluating satoreotide and DOTA-TATE radiolabelled with different radionuclides. Irrespective of the radionuclides used, satoreotide demonstrated a higher pre-clinical anti-tumour efficacy when compared to DOTA-TATE which was less potent and required increased dose levels. Satoreotide was well tolerated across all dose levels and with all used radionuclides. These comparisons…
PR Newswire
22/10/2024

University hospitals in the UK join Homerton Healthcare's public cloud service…

"We cooperate extensively with Homerton to ensure the patients in our region receive timely care, and therefore see huge benefits of further facilitating that collaboration. By having a joint Sectra solution, our radiologists will have immediate access to each other's images and patient data, which will make it easier for us to collaborate around patient cases," says David Newey, Interim Chief Digital Transformation Officer at BHRUT. "We cooperate extensively with Homerton to…
PR Newswire
22/10/2024
Altri  Comunicati